Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02219230 · ClinicalTrials.gov registry record · NA
Use of Passive, Adaptive, and Active Prosthetic Knees in Persons With Unilateral, Transfemoral Amputation
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02219230: Completed NA study, sponsored by University of Washington.
NCT02219230 is a NA study that has completed, run by University of Washington. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02219230, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The goals of this study are to assess measured, observed, and self-reported outcomes achieved through the use of passive (mechanical), active(motorized) and adaptive (magnetorheological) prosthetic knee control systems in individuals with unilateral, transfemoral amputation.
Primary Outcome
Timed performance test that measures rising from a chair, walking 3m, and returning to a seated position.
Interventions
- DEVICE Active knee (Ossur Power Knee II)
- DEVICE Adaptive knee (Ossur Rheo)
- DEVICE Passive knee (Various manufacturers)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT02219230 record still lists
NCT02219230 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Active knee (Ossur Power Knee II) is the first listed.
NCT02219230 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02219230 about?
NCT02219230 is a clinical study titled "Use of Passive, Adaptive, and Active Prosthetic Knees in Persons With Unilateral, Transfemoral Amputation". The goals of this study are to assess measured, observed, and self-reported outcomes achieved through the use of passive (mechanical), active(motorized) and adaptive (magnetorheological) prosthetic knee control systems in individuals with unilateral, transfemoral amputation.
What is the current status of trial NCT02219230?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2011-06. Estimated completion is 2013-09.
What interventions are being tested in trial NCT02219230?
The interventions under investigation include: Active knee (Ossur Power Knee II) (DEVICE), Adaptive knee (Ossur Rheo) (DEVICE), Passive knee (Various manufacturers) (DEVICE).
Who is sponsoring clinical trial NCT02219230?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02219230's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia